Uniting Local and Global Expertise to Address Healthcare Challenges and Foster Innovation
Exploratory collaboration frameworks have been evaluated to assess pathways for strengthening Brazil’s domestic biopharmaceutical manufacturing capabilities, with a particular focus on active pharmaceutical ingredients (APIs), technology transfer models, and long-term industrial development. This feasibility work related to a PDP application formed a part of our broader commitment to evaluating resilient pharmaceutical supply-chain strategies.
These early-stage discussions brought together academic, technical, and private-sector perspectives to examine how public–private collaboration mechanisms might address structural gaps in supply chains, research translation, and domestic production capacity. The work emphasized governance design, institutional alignment, and sequencing considerations rather than transactional outcomes.
The initiative formed part of a broader assessment of Brazil’s life sciences ecosystem and its potential integration with international manufacturing, research, and capital markets platforms. While no formal partnership or program approval resulted from this exploratory phase, the insights gained contributed to the evolution of a wider, multi-jurisdictional platform strategy.
This work remains part of the project’s background research informing future pathways for industrial collaboration, subject to regulatory alignment, institutional participation, and appropriate timing.
Cite: Brazil Press on University Initiative to Produce API
Full Gallery: UNI Venture Group Founder, Nathan BenAmoz during his trip to CPHI India.
